Sanara Medtech Inc (SMTI) — Cash Flow Reinvestment Rate

Latest as of December 2025: 0.62x

Sanara Medtech Inc (SMTI) has a Cash Flow Reinvestment Rate of 0.62x as of December 2025, reinvesting $2.45 Million (capex $82.16K plus investments $-2.36 Million) from operating cash flow of $3.95 Million. Explore SMTI capex reinvestment rate to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.62x
(Capex + Investments) / Operating CF

Total Reinvested

$2.45 Million
Capex + Investments

Operating Cash Flow

$3.95 Million
USD

Capital Expenditures

$82.16K
USD

Sanara Medtech Inc Cash Flow Reinvestment Rate (2016–2025)

Historical reinvestment intensity for Sanara Medtech Inc across 3 annual periods. Also explore Sanara Medtech Inc total assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Sanara Medtech Inc (2016–2025)

Year-by-year capital reinvestment analysis for Sanara Medtech Inc. For live market cap and broader valuation context, see SMTI stock market capitalisation.

Year Reinvestment Rate Total Reinvested (USD) Operating CF Capex YoY Change
2025 1.90x $12.89 Million $6.79 Million $4.63 Million ▼ -52.5%
2018 4.00x $1.11 Million $277.14K $8.48K ▲ +26919.7%
2016 0.01x $6.06K $409.25K $3.03K
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow